416
Participants
Start Date
June 15, 2012
Primary Completion Date
June 10, 2019
Study Completion Date
June 10, 2019
Idelalisib
Idelalisib 150 mg administered orally twice daily
Rituximab
Rituximab 375 mg/m\^2 on Day 1, then 500 mg/m\^2 every 28 days administered intravenously for a maximum of 6 infusions
Bendamustine
Bendamustine 70 mg/mg\^2/day on 2 consecutive days every 28 days administered intravenously for a maximum of 12 infusions
Placebo to match idelalisib
Placebo to match idelalisib administered orally twice daily
Semmelweis Egyetem, Budapest
Országos Onkológiai Intézet, Budapest
St Vincent's Hospital - Sydney, Darlinghurst
Ziekenhuisnetwerk Antwerpen - AZ Stuivenberg, Antwerp
Gosford Hospital, Gosford
UZ Leuven, Leuven
Monash Medical Centre - Clayton Campus, Clayton
Debreceni Egyetem Orvos- és Egészségtudományi Centrum, Debrecen
Princess Alexandra Hospital, Woolloongabba
Princess Alexandra Hospital, Woolloongabba
Royal Adelaide Hospital, Adelaide
Sir Charles Gairdner Hospital, Nedlands
Ankara University Medical Faculty, Ankara
Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ, Szeged
Tallian Gyula utca 20-32, Kaposvár
Hospital Clinic de Barcelona, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
UZ Gent, Ghent
Ospedale Oncologico Regionale A. Businco, Cagliari
"Clinical Hospital Dubrava", Zagreb
Klinichki Bolnicki Centar-Zagreb, Zagreb
University Hospital Merkur, Zagreb
Memorial Sloan Kettering Cancer Center, New York
Columbia University Medical Center, New York
Azienda Ospedaliera Universitaria San Giovanni Battista-Molinette, Torino
North Shore University Hospital, Manhasset
Long Island Jewish Medical Center, New Hyde Park
G. Genimatas Hospital, Athens
"Colentina Clinical Hospital", Bucharest
IRCCS Ospedale San Raffaele, Milan
"Fundeni Clinical Institute", Bucharest
Spedali Civili di Brescia, Brescia
University General Hospital of Patras, Pátrai
Hospital Universitario de La Princesa, Madrid
Hospital 12 de Octubre, Madrid
Hospital Universitario Puerta de Hierro, Majadahonda
Charleston Hematology Oncology, Charleston
Winship Cancer Institute at Emory University, Atlanta
Hopital Purpan, Toulouse
University of Florida, Gainesville
Istanbul University Istanbul Medical Faculty, Istanbul
Clearview Cancer Institute, Huntsville
Medical College of Wisconsin, Milwaukee
Hôpitaux de Brabois, Vandoeuvre-lés-Nancy
Ondokuz Mayis University Faculty of Medicine, Samsun
CHRU Lille-Hôpital Claude Huriez, Lille
Centre Hospitalier de Mulhouse, Mulhouse
University of Nebraska Medical Center, Omaha
Centre Léon Bérard - Centre régional de lutte contre le cancer Rhône-Alpes, Lyon
Centre Jean Bernard - Clinique Victor Hugo, Le Mans
Texas Oncology PA, Dallas
Texas Oncology, Fort Worth
University of Texas MD Anderson Cancer Center, Houston
Texas Oncology, Austin
Rocky Mountain Cancer Center, Denver
UCLA Medical Center, Los Angeles
Hopital Henri Mondor, Créteil
Stanford Cancer Center, Palo Alto
Willamette Valley Cancer Center, Eugene
Seattle Cancer Care Alliance, Seattle
Virginia Cancer Specialists, PC, Vancouver
Cancer Care Northwest, US Oncology, Spokane
Russian Oncology Research Center (N.N. Blokhin), Moscow
Research Institute of Hematology and Blood Transfusion, Saint Petersburg
Ryazan Regional Clinical Hospital, Ryazan
State Budgetary Healthcare Institution Volgograd Regional Clinical Oncology Dispensary #1, Volgograd
Saratov State Medical University, Saratov
Emergency County Clinical Hospital Brasov, Brasov
Nizhegorodskaya Regional Clinical Hospital n.a. N.A. Semashko, Nizhny Novgorod
Regional Oncology Institute Iasi, Iași
Dana Farber Cancer Institute, Boston
Summit Medical Group, P.A., Morristown
Cancer Care Manitoba, Winnipeg
Fakultni nemocnice Brno, Brno
Fakultní nemocnice Hradec Králové, Hradec Králové
Fakultni nemocnice Ostrava, Ostrava
CHU Hôtel-Dieu-Service Hématologie, Nantes
Centre Hospitalier Lyon Sud, Pierre-Bénite
Mater Misericordiae Hospital, Dublin
Novosibirsk State Regional Clinical Hospital, Novosibirsk
Szpital Specjalistyczny w Brzozowie, Brzozów
Malopolskie Centrum Medyczne, Krakow
Wojewodzki Szpital Specjalistyczny im. M. Kopernika w Lodzi, Lodz
Samodzielny Publiczny Szpital Kliniczny Nr 1, Lublin
Wojewodzki Szpital w Opolu, Opole
Centralny Szpital Kliniczny MSW w Warszawie, Warsaw
Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Warsaw
Hospital Santa Maria, Lisbon
"Instituto Portugues de Oncologia do Porto Francisco Gentil (IPOPFG, EPE)", Porto
Hospital Universitario Germans Trias i Pujol, Badalona
Gazi University Medical Faculty Gazi Hospital, Ankara
Birmingham Heartlands Hospital, Birmingham
Kent and Canterbury Hospital, Canterbury
University Hospital of Wales, Cardiff
Dorset County Hospital, Dorchester
St. James University Hospital, Leeds
Royal Liverpool University Hospital, Liverpool
St Bartholomews Hospital, London
King's College Hospital, London
Hammersmith Hospital, London
University College London, London
Christie Hospital, Manchester
Nottingham University Hospitals NHS Trust, Nottingham
Churchill Hospital, Oxford
Royal Cornwall Hospital, Truro
New Cross Hospital, Wolverhampton
Lead Sponsor
Gilead Sciences
INDUSTRY